Vojtíšek Radovan, Mužík Jan, Slampa Pavel, Budíková Marie, Hejsek Jaroslav, Smolák Petr, Ferda Jiří, Fínek Jindřich
Department of Oncology and Radiotherapy, University Hospital in Pilsen, alej Svobody 80, 304 60 Pilsen, Czech Republic.
Department of Radiation Oncology, Masaryk Memorial Cancer Institute in Brno, Žlutý kopec 543/7, 602 00 Brno, Czech Republic.
Rep Pract Oncol Radiother. 2013 Oct 17;19(3):182-90. doi: 10.1016/j.rpor.2013.09.006. eCollection 2014 May.
To compare radiotherapy plans made according to CT and PET/CT and to investigate the impact of changes in target volumes on tumour control probability (TCP), normal tissue complication probability (NTCP) and the impact of PET/CT on the staging and treatment strategy.
Contemporary studies have proven that PET/CT attains higher sensitivity and specificity in the diagnosis of lung cancer and also leads to higher accuracy than CT alone in the process of target volume delineation in NSCLC.
Between October 2009 and March 2012, 31 patients with locally advanced NSCLC, who had been referred to radical radiotherapy were involved in our study. They all underwent planning PET/CT examination. Then we carried out two separate delineations of target volumes and two radiotherapy plans and we compared the following parameters of those plans: staging, treatment purpose, the size of GTV and PTV and the exposure of organs at risk (OAR). TCP and NTCP were also compared.
PET/CT information led to a significant decrease in the sizes of target volumes, which had the impact on the radiation exposure of OARs. The reduction of target volume sizes was not reflected in the significant increase of the TCP value. We found that there is a very strong direct linear relationship between all evaluated dosimetric parameters and NTCP values of all evaluated OARs.
Our study found that the use of planning PET/CT in the radiotherapy planning of NSCLC has a crucial impact on the precise determination of target volumes, more precise staging of the disease and thus also on possible changes of treatment strategy.
比较根据CT和PET/CT制定的放射治疗计划,并研究靶区体积变化对肿瘤控制概率(TCP)、正常组织并发症概率(NTCP)的影响以及PET/CT对分期和治疗策略的影响。
当代研究已证明,PET/CT在肺癌诊断中具有更高的灵敏度和特异性,并且在非小细胞肺癌(NSCLC)靶区体积勾画过程中比单独使用CT具有更高的准确性。
2009年10月至2012年3月,31例被转诊接受根治性放疗的局部晚期NSCLC患者参与了我们的研究。他们均接受了PET/CT计划检查。然后我们对靶区体积进行了两次单独勾画并制定了两个放射治疗计划,并比较了这些计划的以下参数:分期、治疗目的、大体肿瘤体积(GTV)和计划靶体积(PTV)的大小以及危及器官(OAR)的受照剂量。还比较了TCP和NTCP。
PET/CT信息导致靶区体积显著减小,这对OAR的辐射剂量产生了影响。靶区体积的减小并未反映在TCP值的显著增加上。我们发现,所有评估的剂量学参数与所有评估的OAR的NTCP值之间存在非常强的直接线性关系。
我们的研究发现,在NSCLC放射治疗计划中使用PET/CT对精确确定靶区体积、更精确的疾病分期以及因此对治疗策略的可能改变具有至关重要的影响。